Selected research
Industry Growth & Trends
Global Cellular Therapy Products Industry Growth and Trends Forecast to 2032
Market perspective
The global Cellular Therapy Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Cellular Therapy Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Cellular Therapy Products is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cellular Therapy Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Cellular Therapy Products include Beike Biotechnology, Fujifilm Cellular Dynamics, Gilead Sciences, Golden Meditech, Guanhao Biotech, JCR Pharmaceuticals, Osiris, Vcanbio and Vericel Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Cellular Therapy Products market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Cellular Therapy Products market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cellular Therapy Products market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cellular Therapy Products.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Cellular Therapy Products market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Cellular Therapy Products Market by Company
Beike Biotechnology
Fujifilm Cellular Dynamics
Gilead Sciences
Golden Meditech
Guanhao Biotech
JCR Pharmaceuticals
Osiris
Vcanbio
Vericel Corporation
Novartis
Cellular Therapy Products Segment by Type
Stem Cell Type
Non-Stem Cell Type
Cellular Therapy Products Segment by Application
Hospital
Clinic
Others
Cellular Therapy Products Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cellular Therapy Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cellular Therapy Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cellular Therapy Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cellular Therapy Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Cellular Therapy Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Stem Cell Type
- Non-Stem Cell Type
Applications
- Hospital
- Clinic
- Others
Companies covered
- Beike Biotechnology
- Fujifilm Cellular Dynamics
- Gilead Sciences
- Golden Meditech
- Guanhao Biotech
- JCR Pharmaceuticals
- Osiris
- Vcanbio
- Vericel Corporation
- Novartis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Cellular Therapy Products Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Cellular Therapy Products Sales Estimates and Forecasts (2021-2032)
- 1.3 Cellular Therapy Products Market by Type
- 1.3.1 Stem Cell Type
- 1.3.2 Non-Stem Cell Type
- 1.4 Global Cellular Therapy Products Market Size by Type
- 1.4.1 Global Cellular Therapy Products Market Size Overview by Type (2021-2032)
- 1.4.2 Global Cellular Therapy Products Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Cellular Therapy Products Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Cellular Therapy Products Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Cellular Therapy Products Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Cellular Therapy Products Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Cellular Therapy Products Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Cellular Therapy Products Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Cellular Therapy Products Industry Trends
- 2.2 Cellular Therapy Products Industry Drivers
- 2.3 Cellular Therapy Products Industry Opportunities and Challenges
- 2.4 Cellular Therapy Products Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Cellular Therapy Products Revenue (2021-2026)
- 3.2 Global Top Players by Cellular Therapy Products Sales (2021-2026)
- 3.3 Global Top Players by Cellular Therapy Products Price (2021-2026)
- 3.4 Global Cellular Therapy Products Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cellular Therapy Products Major Company Production Sites & Headquarters
- 3.6 Global Cellular Therapy Products Company, Product Type & Application
- 3.7 Global Cellular Therapy Products Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cellular Therapy Products Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cellular Therapy Products Players Market Share by Revenue in 2025
- 3.8.3 2025 Cellular Therapy Products Tier 1, Tier 2, and Tier 3
4 Cellular Therapy Products Regional Status and Outlook
- 4.1 Global Cellular Therapy Products Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Cellular Therapy Products Historic Market Size by Region
- 4.2.1 Global Cellular Therapy Products Sales in Volume by Region (2021-2026)
- 4.2.2 Global Cellular Therapy Products Sales in Value by Region (2021-2026)
- 4.2.3 Global Cellular Therapy Products Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Cellular Therapy Products Forecasted Market Size by Region
- 4.3.1 Global Cellular Therapy Products Sales in Volume by Region (2027-2032)
- 4.3.2 Global Cellular Therapy Products Sales in Value by Region (2027-2032)
- 4.3.3 Global Cellular Therapy Products Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cellular Therapy Products by Application
- 5.1 Cellular Therapy Products Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Cellular Therapy Products Market Size by Application
- 5.2.1 Global Cellular Therapy Products Market Size Overview by Application (2021-2032)
- 5.2.2 Global Cellular Therapy Products Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Cellular Therapy Products Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Cellular Therapy Products Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Cellular Therapy Products Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Cellular Therapy Products Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Cellular Therapy Products Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Cellular Therapy Products Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Beike Biotechnology
- 6.1.1 Beike Biotechnology Company Information
- 6.1.2 Beike Biotechnology Business Overview
- 6.1.3 Beike Biotechnology Cellular Therapy Products Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Beike Biotechnology Cellular Therapy Products Product Portfolio
- 6.1.5 Beike Biotechnology Recent Developments
- 6.2 Fujifilm Cellular Dynamics
- 6.2.1 Fujifilm Cellular Dynamics Company Information
- 6.2.2 Fujifilm Cellular Dynamics Business Overview
- 6.2.3 Fujifilm Cellular Dynamics Cellular Therapy Products Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Fujifilm Cellular Dynamics Cellular Therapy Products Product Portfolio
- 6.2.5 Fujifilm Cellular Dynamics Recent Developments
- 6.3 Gilead Sciences
- 6.3.1 Gilead Sciences Company Information
- 6.3.2 Gilead Sciences Business Overview
- 6.3.3 Gilead Sciences Cellular Therapy Products Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Gilead Sciences Cellular Therapy Products Product Portfolio
- 6.3.5 Gilead Sciences Recent Developments
- 6.4 Golden Meditech
- 6.4.1 Golden Meditech Company Information
- 6.4.2 Golden Meditech Business Overview
- 6.4.3 Golden Meditech Cellular Therapy Products Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Golden Meditech Cellular Therapy Products Product Portfolio
- 6.4.5 Golden Meditech Recent Developments
- 6.5 Guanhao Biotech
- 6.5.1 Guanhao Biotech Company Information
- 6.5.2 Guanhao Biotech Business Overview
- 6.5.3 Guanhao Biotech Cellular Therapy Products Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Guanhao Biotech Cellular Therapy Products Product Portfolio
- 6.5.5 Guanhao Biotech Recent Developments
- 6.6 JCR Pharmaceuticals
- 6.6.1 JCR Pharmaceuticals Company Information
- 6.6.2 JCR Pharmaceuticals Business Overview
- 6.6.3 JCR Pharmaceuticals Cellular Therapy Products Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 JCR Pharmaceuticals Cellular Therapy Products Product Portfolio
- 6.6.5 JCR Pharmaceuticals Recent Developments
- 6.7 Osiris
- 6.7.1 Osiris Company Information
- 6.7.2 Osiris Business Overview
- 6.7.3 Osiris Cellular Therapy Products Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Osiris Cellular Therapy Products Product Portfolio
- 6.7.5 Osiris Recent Developments
- 6.8 Vcanbio
- 6.8.1 Vcanbio Company Information
- 6.8.2 Vcanbio Business Overview
- 6.8.3 Vcanbio Cellular Therapy Products Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Vcanbio Cellular Therapy Products Product Portfolio
- 6.8.5 Vcanbio Recent Developments
- 6.9 Vericel Corporation
- 6.9.1 Vericel Corporation Company Information
- 6.9.2 Vericel Corporation Business Overview
- 6.9.3 Vericel Corporation Cellular Therapy Products Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Vericel Corporation Cellular Therapy Products Product Portfolio
- 6.9.5 Vericel Corporation Recent Developments
- 6.10 Novartis
- 6.10.1 Novartis Company Information
- 6.10.2 Novartis Business Overview
- 6.10.3 Novartis Cellular Therapy Products Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Novartis Cellular Therapy Products Product Portfolio
- 6.10.5 Novartis Recent Developments
7 North America by Country
- 7.1 North America Cellular Therapy Products Sales by Country
- 7.1.1 North America Cellular Therapy Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Cellular Therapy Products Sales by Country (2021-2026)
- 7.1.3 North America Cellular Therapy Products Sales Forecast by Country (2027-2032)
- 7.2 North America Cellular Therapy Products Market Size by Country
- 7.2.1 North America Cellular Therapy Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Cellular Therapy Products Market Size by Country (2021-2026)
- 7.2.3 North America Cellular Therapy Products Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Cellular Therapy Products Sales by Country
- 8.1.1 Europe Cellular Therapy Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Cellular Therapy Products Sales by Country (2021-2026)
- 8.1.3 Europe Cellular Therapy Products Sales Forecast by Country (2027-2032)
- 8.2 Europe Cellular Therapy Products Market Size by Country
- 8.2.1 Europe Cellular Therapy Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Cellular Therapy Products Market Size by Country (2021-2026)
- 8.2.3 Europe Cellular Therapy Products Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Cellular Therapy Products Sales by Country
- 9.1.1 Asia-Pacific Cellular Therapy Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Cellular Therapy Products Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Cellular Therapy Products Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Cellular Therapy Products Market Size by Country
- 9.2.1 Asia-Pacific Cellular Therapy Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Cellular Therapy Products Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Cellular Therapy Products Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Cellular Therapy Products Sales by Country
- 10.1.1 South America Cellular Therapy Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Cellular Therapy Products Sales by Country (2021-2026)
- 10.1.3 South America Cellular Therapy Products Sales Forecast by Country (2027-2032)
- 10.2 South America Cellular Therapy Products Market Size by Country
- 10.2.1 South America Cellular Therapy Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Cellular Therapy Products Market Size by Country (2021-2026)
- 10.2.3 South America Cellular Therapy Products Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Cellular Therapy Products Sales by Country
- 11.1.1 Middle East and Africa Cellular Therapy Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Cellular Therapy Products Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Cellular Therapy Products Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Cellular Therapy Products Market Size by Country
- 11.2.1 Middle East and Africa Cellular Therapy Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Cellular Therapy Products Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Cellular Therapy Products Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Cellular Therapy Products Value Chain Analysis
- 12.1.1 Cellular Therapy Products Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Cellular Therapy Products Production Mode & Process
- 12.2 Cellular Therapy Products Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Cellular Therapy Products Distributors
- 12.2.3 Cellular Therapy Products Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst